Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
If you do not agree to our Terms with this Policy, or if you violate them in any way, your right to access or use the Services is terminated
While previous generations of treatments focused on one or two hormonal pathways, Retatrutide targets three distinct receptors simultaneously: GLP-1 (Glucagon-like Peptide-1): Mimics the hormone that slows gastric emptying and signals satiety to the brain to reduce food intake
View Product Clinical Trial Data: Women vs Men Results How Retatrutide Works in Female Bodies Side Effects Women Should Expect Hormonal Considerations and Menstrual Cycles Birth Control Interactions Pregnancy, Breastfeeding, and Fertility Perimenopause and Menopause Considerations PCOS and Insulin Resistance Dosing Recommendations for Women Nutritional Needs During Treatment Preserving Muscle Mass Body Image and Mental Health Accessing Retatrutide in Canada Frequently Asked Questions Glossary of Terms References Clinical Trial Data: What the Research Shows for Women The question of whether women can take Retatrutide gets a definitive answer from Phase 2 clinical trial data
Arg substitution at position 34 Formula / M.W.: C 187 H 291 N 45 O 59 , ~4113.58 g/mol CAS: 910463-68-2 Disclaimer This product is intended for laboratory research use only
If you use compounded tirzepatide from multi-dose vials, the same principle applies
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia possible contribution to impaired incretin effects in diabetes
